Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Conroy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunological Reviews|May 20, 2003
Caspase-activation pathways in apoptosis and immunityEmma M Creagh, Helen Conroy, Seamus J Martin
Cancer Immunology, Immunotherapy : CII|December 24, 2011
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cellsHelen Conroy, Karen C Galvin, Sarah C Higgins, et al.
Genes, Chromosomes & Cancer|March 28, 2003
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)Alain Charest, Keara Lane, Kevin McMahon, et al.
Vaccine|May 16, 2008
Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanomaDeirdre Toomey, Helen Conroy, Andrew G Jarnicki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell deathAoife P Boyd, Pádraig J Ross, Helen Conroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeuticsAndrew G Jarnicki, Helen Conroy, Corinna Brereton, et al.
Molecular Medicine (Cambridge, Mass.)|April 1, 2015
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancerLeona Mawhinney, Michelle E Armstrong, Ciaran O' Reilly, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunological Reviews|May 20, 2003
Caspase-activation pathways in apoptosis and immunityEmma M Creagh, Helen Conroy, Seamus J Martin
Cancer Immunology, Immunotherapy : CII|December 24, 2011
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cellsHelen Conroy, Karen C Galvin, Sarah C Higgins, et al.
Genes, Chromosomes & Cancer|March 28, 2003
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)Alain Charest, Keara Lane, Kevin McMahon, et al.
Vaccine|May 16, 2008
Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanomaDeirdre Toomey, Helen Conroy, Andrew G Jarnicki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell deathAoife P Boyd, Pádraig J Ross, Helen Conroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeuticsAndrew G Jarnicki, Helen Conroy, Corinna Brereton, et al.
Molecular Medicine (Cambridge, Mass.)|April 1, 2015
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancerLeona Mawhinney, Michelle E Armstrong, Ciaran O' Reilly, et al.
Pageof 1